FDA approves Vivus's fast-acting Viagra rival
The US Food and Drug Administration (FDA) voted on Friday to approve a new drug to treat erectile dysfunction (ED), various media outlets have reported. The medication, Stendra (genetic name: avanafil), is produced by California-based pharmaceutical company Vivus Inc. and is the first product from that company to receive FDA approval, according to Jennifer Corbett Dooren of the Wall Street Journal. Like Viagra, Cialis, and Levitra, Stendra is a phosphodiesterase type 5 (PDE-5) inhibitor which works by increasing blood flow to the penis, Medical News Today said Friday. It is the first PDE-5 inhibitor to be approved by the federal drug agency in a decade, added MedPage Today Staff Writer Charles Bankhead. "This approval expands the available treatment options to men experiencing erectile dysfunction, and enables patients, in consultation with their doctor, to choose the most appropriate treatment for their needs," Dr. Victoria Kusiak, deputy director of the Office of Drug Evaluation III in the FDA's Center for
Men with erectile dysfunction may not have to plan for sex as far in advance anymore after Vivus Inc won U.S. approval for avanafil, its faster acting rival to Viagra
Mon 30 Apr 12 from FOXNews
WASHINGTON (Reuters) - U.S. health regulators on Friday approved Vivus Inc.'s avanafil treatment for erectile dysfunction, giving the small company, which has struggled to bring a weight loss ...
Fri 27 Apr 12 from Reuters
The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.
Sat 28 Apr 12 from HealthCanal
WASHINGTON (MedPage Today) -- The PDE-5 inhibitor class of drugs for erectile dysfunction gained its first new member in a decade with the FDA approval of avanafil (Stendra).
Fri 27 Apr 12 from MedPageToday
The FDA has approved Stendra (avanafil) for men with erectile dysfunction (ED).
Fri 27 Apr 12 from WebMD
The US Food and Drug Administration (FDA) voted on Friday to approve a new drug to treat erectile dysfunction (ED), various media outlets have reported. The medication, Stendra (genetic name: ...
Sat 28 Apr 12 from RedOrbit
The Food and Drug Administration on Friday approved a new impotence drug, Vivus Inc.'s Stendra.The pill is intended to be taken 30 minutes before sex, but Vivus said that in clinical trials, ...
Fri 27 Apr 12 from R&D Mag
- Pages: 1